Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Clinical trial NCT02231853 · TERMINATED

Trial details

NCT number

NCT02231853

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-09-03

Primary completion

2017-11-17

Enrollment

12

View on ClinicalTrials.gov